Back to Previous Page

OGG1 Inhibitor O8 >=98% (HPLC)

ITEM#: 3042-SML169725MG

MFR#: SML1697-25MG

Inhibition of 8-oxoguanine DNA glycosylase-1 (OGG1) can be used in monotherapy or in combination therapy to treat some types of cancer.

See More Details
Inhibition of 8-oxoguanine DNA glycosylase-1 (OGG1) can be used in monotherapy or in combination therapy to treat some types of cancer.
Provide Content Correction
Product Name Description Item# QTY
OGG1 Inhibitor O8 >=98% (HPLC) Inhibition of 8-oxoguanine DNA glycosylase-1 (OGG1) can be used in monotherapy or in combination therapy to treat some types of cancer. 3042-SML16975MG EA
Manufacturer Default Logo Src Inhibitor-1 >=98% (HPLC) Src Inhibitor-1 >=98% (HPLC) 3042-S207525MG EA
DDR1 Inhibitor 7rh >=98% (HPLC) DDR1 Inhibitor 7rh is a small potent kinase inhibitor of discoidin domain receptor-1 (DDR1). It inhibits the tumorigenicity of nasopharyngeal carcinoma (NPC) cells. DDR1 Inhibitor 7rh prevents the proliferation, invasion and adhesion of cancer cells. 3042-SML183225MG EA
Thank you for visiting. We look forward to serving you!

Read more about us:  Franklin Young Value



For Government, Military, Education and Government Prime Access:


New Customers Existing Customers

Please contact Customer Service with your questions.

Thank you for visiting, your account is pending approval.

You will received email notification for approval within 24hrs.

Contact customerservice@franklinyoung.com for any questions.

Thank you for requesting an account with Franklin Young.

Your request has been declined

We restrict website access to government entities, and related customers.

Please contact customerservice@franklinyoung.com with any questions.